Skip to main content
Clinical Trials/JPRN-UMIN000032237
JPRN-UMIN000032237
Recruiting
未知

Inception Cohort Registry Study of Patients with Crohn's disease - CD Registry Study

Janssen Pharma K.K.0 sites900 target enrollmentApril 13, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Crohn&#39
Sponsor
Janssen Pharma K.K.
Enrollment
900
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2018
End Date
June 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Janssen Pharma K.K.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients who have used a biological drug having an indication for auto\-immune diseases before diagnosis of CD 2\.Patients with unknown dates (month and year) of CD diagnosis. 3\.Patients currently enrolled or expected to be enrolled in other registration trial(s) at the registry entry.

Outcomes

Primary Outcomes

Not specified

Similar Trials